Logo image of AZPN

ASPEN TECHNOLOGY INC (AZPN) Stock Fundamental Analysis

NASDAQ:AZPN - Nasdaq - US29109X1063 - Common Stock - Currency: USD

264.33  +0.03 (+0.01%)

After market: 264.6 +0.27 (+0.1%)

Fundamental Rating

5

Taking everything into account, AZPN scores 5 out of 10 in our fundamental rating. AZPN was compared to 282 industry peers in the Software industry. AZPN has a great financial health rating, but its profitability evaluates not so good. AZPN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AZPN was profitable.
AZPN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AZPN reported negative net income in multiple years.
Each year in the past 5 years AZPN had a positive operating cash flow.
AZPN Yearly Net Income VS EBIT VS OCF VS FCFAZPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

AZPN has a better Return On Assets (-0.07%) than 60.85% of its industry peers.
Looking at the Return On Equity, with a value of -0.08%, AZPN is in the better half of the industry, outperforming 62.28% of the companies in the same industry.
Industry RankSector Rank
ROA -0.07%
ROE -0.08%
ROIC N/A
ROA(3y)-0.15%
ROA(5y)8.06%
ROE(3y)-0.17%
ROE(5y)17.74%
ROIC(3y)N/A
ROIC(5y)N/A
AZPN Yearly ROA, ROE, ROICAZPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

AZPN has a Gross Margin of 66.07%. This is comparable to the rest of the industry: AZPN outperforms 48.40% of its industry peers.
In the last couple of years the Gross Margin of AZPN has declined.
The Profit Margin and Operating Margin are not available for AZPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.29%
GM growth 5Y-6.06%
AZPN Yearly Profit, Operating, Gross MarginsAZPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

9

2. Health

2.1 Basic Checks

AZPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZPN has been reduced compared to 1 year ago.
The number of shares outstanding for AZPN has been reduced compared to 5 years ago.
AZPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AZPN Yearly Shares OutstandingAZPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
AZPN Yearly Total Debt VS Total AssetsAZPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

AZPN has an Altman-Z score of 8.76. This indicates that AZPN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AZPN (8.76) is better than 82.21% of its industry peers.
AZPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.76
ROIC/WACCN/A
WACC10.78%
AZPN Yearly LT Debt VS Equity VS FCFAZPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 3.33 indicates that AZPN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.33, AZPN is in the better half of the industry, outperforming 76.87% of the companies in the same industry.
AZPN has a Quick Ratio of 3.33. This indicates that AZPN is financially healthy and has no problem in meeting its short term obligations.
AZPN's Quick ratio of 3.33 is fine compared to the rest of the industry. AZPN outperforms 76.87% of its industry peers.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 3.33
AZPN Yearly Current Assets VS Current LiabilitesAZPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.03% over the past year.
The Earnings Per Share has been growing by 9.94% on average over the past years. This is quite good.
AZPN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.98%.
The Revenue has been growing by 13.57% on average over the past years. This is quite good.
EPS 1Y (TTM)22.03%
EPS 3Y8.27%
EPS 5Y9.94%
EPS Q2Q%50.36%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y16.7%
Revenue growth 5Y13.57%
Sales Q2Q%18.04%

3.2 Future

Based on estimates for the next years, AZPN will show a small growth in Earnings Per Share. The EPS will grow by 7.03% on average per year.
AZPN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.75% yearly.
EPS Next Y17.25%
EPS Next 2Y11.33%
EPS Next 3Y10.88%
EPS Next 5Y7.03%
Revenue Next Year7.88%
Revenue Next 2Y7.71%
Revenue Next 3Y7.91%
Revenue Next 5Y8.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AZPN Yearly Revenue VS EstimatesAZPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
AZPN Yearly EPS VS EstimatesAZPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

AZPN is valuated quite expensively with a Price/Earnings ratio of 37.87.
61.57% of the companies in the same industry are more expensive than AZPN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.30. AZPN is valued slightly more expensive when compared to this.
AZPN is valuated quite expensively with a Price/Forward Earnings ratio of 32.31.
Based on the Price/Forward Earnings ratio, AZPN is valued a bit cheaper than the industry average as 64.77% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of AZPN to the average of the S&P500 Index (21.76), we can say AZPN is valued slightly more expensively.
Industry RankSector Rank
PE 37.87
Fwd PE 32.31
AZPN Price Earnings VS Forward Price EarningsAZPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

68.68% of the companies in the same industry are more expensive than AZPN, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as AZPN.
Industry RankSector Rank
P/FCF 54.42
EV/EBITDA 40.9
AZPN Per share dataAZPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.2
PEG (5Y)3.81
EPS Next 2Y11.33%
EPS Next 3Y10.88%

More info and screens

0

5. Dividend

5.1 Amount

AZPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASPEN TECHNOLOGY INC

NASDAQ:AZPN (3/11/2025, 8:00:02 PM)

After market: 264.6 +0.27 (+0.1%)

264.33

+0.03 (+0.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)N/A N/A
Inst Owners46.66%
Inst Owner Change0%
Ins Owners0.05%
Ins Owner Change-58.82%
Market Cap16.73B
Analysts73.75
Price Target272.83 (3.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.49
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.3%
Min EPS beat(2)-46.89%
Max EPS beat(2)8.29%
EPS beat(4)3
Avg EPS beat(4)-3.07%
Min EPS beat(4)-46.89%
Max EPS beat(4)14.53%
EPS beat(8)3
Avg EPS beat(8)-11%
EPS beat(12)5
Avg EPS beat(12)-6.65%
EPS beat(16)7
Avg EPS beat(16)-4.89%
Revenue beat(2)1
Avg Revenue beat(2)-9.99%
Min Revenue beat(2)-20.92%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-20.92%
Max Revenue beat(4)6.27%
Revenue beat(8)3
Avg Revenue beat(8)-5.74%
Revenue beat(12)4
Avg Revenue beat(12)-13.98%
Revenue beat(16)4
Avg Revenue beat(16)-17.24%
PT rev (1m)3.03%
PT rev (3m)9.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.73%
EPS NY rev (1m)0%
EPS NY rev (3m)1.49%
Revenue NQ rev (1m)1.62%
Revenue NQ rev (3m)4.06%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 37.87
Fwd PE 32.31
P/S 14.84
P/FCF 54.42
P/OCF 51.21
P/B 1.31
P/tB 36.33
EV/EBITDA 40.9
EPS(TTM)6.98
EY2.64%
EPS(NY)8.18
Fwd EY3.09%
FCF(TTM)4.86
FCFY1.84%
OCF(TTM)5.16
OCFY1.95%
SpS17.81
BVpS201.82
TBVpS7.28
PEG (NY)2.2
PEG (5Y)3.81
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.07%
FCFM 27.27%
ROA(3y)-0.15%
ROA(5y)8.06%
ROE(3y)-0.17%
ROE(5y)17.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.29%
GM growth 5Y-6.06%
F-Score8
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 3.91%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion 80.75%
Profit Quality N/A
Current Ratio 3.33
Quick Ratio 3.33
Altman-Z 8.76
F-Score8
WACC10.78%
ROIC/WACCN/A
Cap/Depr(3y)2.54%
Cap/Depr(5y)9.1%
Cap/Sales(3y)1%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.03%
EPS 3Y8.27%
EPS 5Y9.94%
EPS Q2Q%50.36%
EPS Next Y17.25%
EPS Next 2Y11.33%
EPS Next 3Y10.88%
EPS Next 5Y7.03%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y16.7%
Revenue growth 5Y13.57%
Sales Q2Q%18.04%
Revenue Next Year7.88%
Revenue Next 2Y7.71%
Revenue Next 3Y7.91%
Revenue Next 5Y8.75%
EBIT growth 1Y51.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.32%
EBIT Next 3Y18.97%
EBIT Next 5Y7.32%
FCF growth 1Y194.26%
FCF growth 3Y5.65%
FCF growth 5Y6.4%
OCF growth 1Y203.73%
OCF growth 3Y7.17%
OCF growth 5Y7.36%